TNF -alpha inhibitors should not be used in:
**Core Concept**
TNF-alpha inhibitors, such as infliximab and adalimumab, are biologic agents that target tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine involved in the pathogenesis of various autoimmune and inflammatory diseases. These medications are used to treat conditions like rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. However, their use is contraindicated in certain situations due to the risk of adverse effects.
**Why the Correct Answer is Right**
The use of TNF-alpha inhibitors is generally avoided in patients with active tuberculosis (TB) or latent TB infection, as these medications can reactivate the disease. This is because TNF-alpha plays a crucial role in containing TB infection, and its inhibition can lead to the spread of Mycobacterium tuberculosis. Additionally, TNF-alpha inhibitors can also increase the risk of other opportunistic infections, such as histoplasmosis and coccidioidomycosis.
**Why Each Wrong Option is Incorrect**
**Option A:** While TNF-alpha inhibitors may increase the risk of infections, they are not contraindicated in patients with a history of infections. In fact, these medications can be used to treat certain types of infections, such as psoriatic arthritis-related dactylitis.
**Option B:** TNF-alpha inhibitors are not contraindicated in patients with a history of malignancy, although caution is advised due to the potential increased risk of certain types of cancer.
**Option C:** While TNF-alpha inhibitors can increase the risk of infections, they are not contraindicated in patients with a history of heart failure. In fact, these medications can be used to treat certain types of heart failure-related conditions.
**Clinical Pearl / High-Yield Fact**
Before initiating TNF-alpha inhibitors, patients should undergo a thorough screening for latent TB infection, including a tuberculin skin test (TST) or interferon-gamma release assay (IGRA). This is essential to prevent the reactivation of TB and minimize the risk of adverse effects.
**Correct Answer:** D.